http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110769848-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8828412a08c427cf0e753b98d7339754
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0029
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
filingDate 2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39f3253129feaa4c68ae496c17b355bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e1f635caf5679fcd099cd346d91b84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41132e08c94cbf9174e725aed89b16fd
publicationDate 2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110769848-A
titleOfInvention C1-esterase inhibitor preparations
abstract The present invention relates to stable C1-esterase inhibitor (C1-Inh) formulations, liquid or lyophilized, characterized by a histidine content of 5-400 mM, but without citrate or phosphate. It also relates to kits containing C1‑Inh preparations.
priorityDate 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009291062-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5681750-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016131958-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015173782-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M7Q5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5F4BTH8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559037
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID767827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550758
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1P6E1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID710

Total number of triples: 42.